Leqembi’s FSS Pricing Meets ICER’s Cost-Effectiveness Threshold; VA Requiring Coverage With Evidence

 
• By Nielsen Hobbs
  
red white and blue brain
• Source: Nielsen Hobbs; the Pink Sheet | Shutterstock image
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Government Payers

More from Market Access